Artificial Pancreas Device Systems Market, By Type (Control to Range, Control to Target, and Threshold-Suspended Device Systems) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI140619 | Publish Date: February 2024 | No. of Pages: 180

Global Artificial Pancreas Device Market Companies

  • Defymed SAS
  • TypeZero Technologies, Inc.
  • Insulet Corporation
  • Bigfoot Biomedical, Inc.
  • Medtronic Plc
  • Dexcom, Inc.
  • Admetsys Corp.
  • Beta Bionics, Inc.
  • Cellnovo Group SA
  • Tandem Diabetes Care, Inc.

Recent News:

  • In April 2024, UK rolls out artificial pancreas for children and adults with type 1 diabetes. Thousands of people with type 1 diabetes will receive an 'artificial pancreas' that will continually track the glucose levels and automatically adjust insulin delivery through a pump. This is the world's first initiative being rolled out by the National Health Service (NHS) England. This technology is called the Hybrid Closed Loop system, also known as 'artificial pancreas'.